JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (6): 114-118.doi: 10.6040/j.issn.1671-7554.0.2016.1275

Previous Articles     Next Articles

Construction of a NAFLD screening tool based on health examination subjects

JIANG Zheng1,2, SHEN Zhenwei1,2, ZHANG Guang3, LI Runzi1,2, CAO Jin1,2, WANG Li4, XUE Fuzhong1,2, LIU Yanxun1,2   

  1. 1. Department of Biostatistics, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    2. Cheeloo Research Center for Biomedical Big Data, Shandong University, Jinan 250012, Shandong, China;
    3. Health Management Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, Shandong, China;
    4. Shandong Electric Power Central Hospital, Jinan 250012, Shandong, China
  • Received:2016-10-09 Online:2017-06-10 Published:2017-06-10

Abstract: Objective To devise and verify a screening model for nonalcoholic fatty liver disease(NAFLD). Methods From the “Shandong Multi-center Longitudinal Cohort for Health Management”, 8,993 health examination clients without excessive drinking habits were randomly selected and divided into 2 groups, internal group(80% subjects, for derivation and internal assessment), and external group(20% subjects, for external assessment). Multivariate stepwise logistic regression was used to build a screening model, and prediction power of the model was assessed. Results Multivariate analysis demonstrated that gender, body mass index(BMI), hypertension, dyslipidemia, aspartate transaminase to alanine aminotransferase ratio(AST/ALT)and fasting blood glucose(FBG)were involved in the model and fatty liver index(FLI)could be constructed. The discriminatory power of the model was tested with the area under the receiver-operating characteristic curve(AUC),(0.859, 95%CI, 0.851 2-0.867 in the internal group, and 0.853, 95%CI, 0.835-0.869 in the external group). When FLI≤1.25 was used to exclude the possibility of NAFLD, the negative predictive value was 93.1% and 93.3% respectively for the internal and external group. When FLI≥2.25 was used to detect NAFLD, the positive predictive value was 74.6% and 72.7% respectively. Conclusion FLI is an effective screening tool for the identification of high-risk subjects of NAFLD.

Key words: Nonalcoholic fatty liver disease, Health examination clients, Fatty liver index, Screening

CLC Number: 

  • R575.5
[1] Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease[J]. Atherosclerosis, 2015, 239(1): 192-202.
[2] Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010[J]. Journal of Digestive Diseases, 2011, 12(1): 38-44.
[3] Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know[J]. World J Gastroenterol, 2014, 20(36): 12956-12980.
[4] Wong VW, Chu WC, Wong GL, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography[J]. Gut, 2012, 61(3): 409-415.
[5] Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(5): 307-318.
[6] Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population[J]. Clin Gastroenterol Hepatol, 2012, 10(6): 646-650.
[7] Park HE, Kwak MS, Kim D, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification development: a longitudinal study[J]. J Clin Endocrinol Metab, 2016, 101(8): 3134-3143.
[8] Kim BJ, Kim NH, Kim BS, et al. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals[J]. Cardiology, 2012, 123(1): 54-61.
[9] Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease[J]. Gut, 2011, 60(12): 1721-1727.
[10] Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy[J]. J Magn Reson Imaging, 2011, 34(4): 729-749.
[11] Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD[J]. Aliment Pharmacol Ther, 2012, 36(1): 22-29.
[12] Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11): 666-675.
[13] 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007,35(5):390-419. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults(no abstract)[J]. Chinese Journal of Cardiology. 2007, 35(5): 390-419.
[14] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中国肝脏病杂志, 2010,18(3):163-166. The Chinese National Workshop on Fatty Liver and Alcohol and Liver Disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chinese Journal of Hepatology, 2010, 18(3): 163-166.
[15] Nalbantoglu IL, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2014, 20(27): 9026-9037.
[16] Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation[J]. Am J Gastroenterol, 2007, 102(12): 2708-2715.
[17] Duman DG, Celikel C, Tuney D, et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?[J]. Dig Dis Sci, 2006, 51(2): 346-351.
[18] Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index[J]. Radiology, 2007, 244(2): 479-485.
[19] Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease[J]. Dig Liver Dis, 2010, 42(7): 503-508.
[20] Park YJ, Lim JH, Kwon ER, et al. Development and validation of a simple index system to predict nonalcoholic fatty liver disease[J]. Korean J Hepatol, 2011, 17(1): 19-26.
[21] Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population[J]. BMC Gastroenterol, 2006, 6(1): 33. doi: 10.1186/1471-230X-6-33.
[22] Zhang T, Zhang C, Zhang Y, et al. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study[J]. Atherosclerosis, 2015, 240(1): 144-148.
[23] Hamaguchi M, Takeda N, Kojima T, et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome[J]. World J Gastroenterol, 2012, 18(13): 1508-1516.
[24] Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?[J]. Mol Cell Endocrinol, 2015, 418: 55-65. doi:10.1016/j.mce.2015.02.018.
[25] Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease[J]. Hepatology, 2007, 46(4): 1081-1090.
[1] LIU Xiaojuan, JIANG Zheng, KANG Fengling, ZHOU Miao, LIN Weiqiang, XUE Fuzhong. Association between neutrophil count and nonalcoholic fatty liver disease:a prospective cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 119-123.
[2] LI Yun, ZHONG Wanxia, YAO Ning, HU Shuanggang, LIU Hongmao. Effects of female age on the outcome of preimplantation genetic diagnosis and screening [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 60-62.
[3] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[4] GAI Linlin, GUAN Lixue, LI Haibo, CHU Jinjin, ZHU Yun, LI Ming. Screening results and influencing factors of T-SPOT.TB assay in patients with autoimmune rheumatic diseases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 82-86.
[5] MENG Yan, ZHANG Jie, YUAN Yuan, ZHANG Jitian, CHEN Liyong. Nutritional risk screening of hospitalized patients and effect evaluation of nutrition therapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 99-102.
[6] LIU Chen-fan1, WANG Zhen-ying2, SONG Huai-dong3, PAN Chun-ming3, ZHANG Li2. Mutation screening of candidate genes causing disseminated superficial porokeratosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 93-97.
[7] CHENG Kai1,2, ZHANG Lin-na1, SUN Ming2, HOU Qian2, ZHANG Min2, YANG Hai-xia2. Screening for retinopathy of prematurity:an analysis of 773 premature babies [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 149-152.
[8] LIU Zhenzhong1, JIANG Duyin1,2, CAI Jinglong3, ZONG Xianlei3, ZHANG Jixun1, SHAN Fei1,2, WANG Wenting1,2, WANG Wei1,2. TGF-β1-related model peptides isolated from a phage  display 12-mer peptide library [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 70-73.
[9] LI Yuyang1,2, DU Jiajun2, LIU Qi2, YU Zhigang1. Screening for breast diseases among 61,102 women in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 157-160.
[10] ZHANG Ling-yun1,2, ZHAO Jia-jun1, JIN Yong-jun2, LI Jian-zhou2. Relationship between nonalcoholic fatty liver disease and  the -420 C/G single  nucleotide polymorphism of resistin  in type 2 diabetes mellitus patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 1-5.
[11] WANG Xiao-yong1, LI Shi-xue2, SUN Xiu-bin2 , PANG Zeng-chang3, QIAO Qing4. Evaluation of effects of five screening methods for  asymptomatic type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 158-162.
[12] SHAO Luo-lin, XU Wei-hua, ZHOU Cheng-jun, WANG Hong-bo, GUO Jian-qiang. Role of Nrf2 on the mechanism of nonalcoholic fatty liver disease in mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 53-56.
[13] LI Shun-ping1, LIU Ting-ting2, CHEN Chun-hui1, LI Yong-mei2. Prevalence rate of nonalcoholic fatty liver disease and its influential factors in Jinan railway workers [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(10): 125-.
[14] ZHANG Chao,ZHANG Dong-rong,HE Wei,DUAN Zuo-ying,MAO Zhong-gui. A simple and sensitive method for screening εPL producing strains from soils [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1104-1107.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!